Biocon earns USFDA nod for Liraglutide injection, boosting its diabetes drug portfolio. Explore investment opportunities now!
The post Nevada Regulators Fine Peptide Providers at Anti-Aging Festival Where Two Women Became Critically Ill appeared first ...
Shanghai Junshi Biosciences Co., Ltd (Junshi Biosciences, HKEX: 1877; SSE: 688180), a leading innovation-driven ...
Why insurance requires an 8 a.m. testosterone test and what causes hand numbness and locking fingers.
Hangzhou Sciwind Biosciences Co., Ltd. ('Sciwind'), a biopharmaceutical company focused on the discovery and development of innovative therapies for metabolic diseases, announced today that China's ...
Biocon said its wholly owned subsidiary Biocon Pharma has received US FDA approval for its ANDA for Liraglutide Injection (gVictoza) 18 mg/3 mL prefilled pens used to treat Type 2 diabetes, following ...
The development was announced in a statement issued on Wednesday by the National AIDS, Viral Hepatitis and STIs Control ...
Biocon Pharma, a subsidiary of Biocon Ltd, has secured approval from the US FDA for its generic Liraglutide injection ...
The company aims to start a pivotal trial this year, file for 510(k) clearance in 2027 and launch the device in 2028.
Paulick Report on MSN
New Betamethasone Study Quantifies Detection Time For Intramuscular Use
A study published in the Journal of Veterinary Pharmacology and Therapeutics on Feb. 7, 2026, has quantified the amount of ...
Zydus Lifesciences will roll out generic semaglutide injections in India post-patent expiry, using a reusable single-pen ...
In December 2025, the FDA approved the first-ever GLP-1 pill for chronic weight management - Novo Nordisk’s oral formulation ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results